Yan Zhongyu, Hoffmann Andrea, Kaiser Erin Kelly, Grunwald William C, Cool David R
Department of Pharmacology & Toxicology, Wright State University, Dayton, OH 45435.
Open Neuroendocrinol J. 2011;4:136-146. doi: 10.2174/1876528901104010136.
Arginine-vasopressin (AVP) is a peptide hormone normally secreted from neuroendocrine cells via the regulated secretory pathway. In Familial Neurohypophyseal Diabetes Insipidus (FNDI), an autosomal dominant form of central diabetes insipidus, mutations of pro-vasopressin appear to accumulate in the endoplasmic reticulum (ER) causing a lack of biologically active AVP in the blood. To investigate the effect of pro-vasopressin mutations regarding intracellular functions of protein targeting and secretion, we created two FNDI-associated amino acid substitution mutants, e.g., G14R, and G17V in frame with green fluorescent protein (GFP) and pro-vasopressin (VP) in frame with red fluorescent protein (VP-RFP). Fluorescence microscopy of Neuro-2a cells expressing these constructs revealed co-localization of VP-GFP and VP-RFP to punctate granules along the length and accumulating at the tips of neurites, characteristic of regulated secretory granules. In contrast, the two FNDI-associated amino acid substitution mutants, e.g., G14R-GFP, and G17VGFP, were localized to a perinuclear region of the Neuro-2a cells characteristic of the endoplasmic reticulum. Co-expression of these mutants with VP-RFP showed VP-RFP was retained in the ER, co-localized with the mutants suggesting the formation of heterodimers as found in FNDI. Stimulated secretion experiments indicated that VP-GFP was secreted in an inducible manner whereas, G14R-GFP and G17V-GFP were retained to nearly 100% within the cells. Analysis by western blotting and semi-quantitative RT-PCR indicated an increased protein and mRNA expression for an ER resident molecular chaperone, BiP. Further analysis of ER-storage disease-associated proteins such as caspase 12 and CHOP showed an increase in these as well. The results suggest that G14R-GFP and G17V-GFP are retained in the ER of Neuro-2a cells, resulting in up-regulation of the molecular chaperone BiP, and activation of the ER-storage disease-associated caspase cascade system.
精氨酸加压素(AVP)是一种肽类激素,通常通过调节性分泌途径从神经内分泌细胞分泌。在家族性垂体性尿崩症(FNDI)中,一种常染色体显性形式的中枢性尿崩症,血管加压素原的突变似乎在内质网(ER)中积累,导致血液中缺乏生物活性AVP。为了研究血管加压素原突变对蛋白质靶向和分泌的细胞内功能的影响,我们构建了两个与FNDI相关的氨基酸替代突变体,例如G14R和G17V,它们与绿色荧光蛋白(GFP)在同一阅读框内,血管加压素原(VP)与红色荧光蛋白(VP-RFP)在同一阅读框内。对表达这些构建体的Neuro-2a细胞进行荧光显微镜观察,发现VP-GFP和VP-RFP共定位于沿细胞长度分布的点状颗粒,并在神经突末端积累,这是调节性分泌颗粒的特征。相反,两个与FNDI相关的氨基酸替代突变体,例如G14R-GFP和G17V-GFP,定位于Neuro-2a细胞的核周区域,这是内质网的特征。这些突变体与VP-RFP共表达显示VP-RFP保留在内质网中,与突变体共定位,提示形成了如在FNDI中发现的异二聚体。刺激分泌实验表明,VP-GFP以诱导方式分泌,而G14R-GFP和G17V-GFP在细胞内几乎100%保留。蛋白质印迹和半定量RT-PCR分析表明,内质网驻留分子伴侣BiP的蛋白质和mRNA表达增加。对内质网储存疾病相关蛋白如半胱天冬酶12和CHOP的进一步分析也显示它们增加。结果表明,G14R-GFP和G17V-GFP保留在Neuro-2a细胞的内质网中,导致分子伴侣BiP上调,并激活内质网储存疾病相关的半胱天冬酶级联系统。